1 |
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). The Journal of the American Medical Association, 285(19), 2486-2497. DOI : 10.1001/jama.285.19.2486
DOI
|
2 |
D. S. Lee et al. (2007). Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(1), 127-133. DOI : 10.1161/01.ATV.0000251993.20372.40
DOI
|
3 |
G. Ndrepepa & A. Kastrati. (2016). Gamma-glutamyl transferase and cardiovascular disease. Annals of Translational Medicine, 4(24), 481. DOI : 10.21037/atm.2016.12.27
DOI
|
4 |
J. B. Whitfield. (2001). Gamma glutamyl transferase. Critical Reviews in Clinical Laboratory Sciences, 38(4), 263-355. DOI : 10.1080/20014091084227
DOI
|
5 |
G. Wannamethee, S. Ebrahim & A. G. Shaper. (1995). Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. American Journal of Epidemiology, 142(7), 699-708. DOI : 10.1093/oxfordjournals.aje.a117699
DOI
|
6 |
D. J. Kim et al. (2005). Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors. Diabetic Medicine, 22(9), 1134-1140. DOI : 10.1111/j.1464-5491.2005.01581.x
DOI
|
7 |
I. Abete, E. Goyenechea, M. A. Zulet & J. A. Martinez. (2011). Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutrition, Metabolism & Cardiovascular Diseases, 21(Suppl 2), B1-B15. DOI : 10.1016/j.numecd.2011.05.001
DOI
|
8 |
Y. Xu et al. (2011). Cross-sectional and longitudinal association of serum alanine aminotransaminase and γ-glutamyltransferase with metabolic syndrome in middle-aged and elderly Chinese people. Journal of Diabetes, 3(1), 38-47. DOI : 10.1111/j.1753-0407.2010.00111.x
DOI
|
9 |
A. C. Hwang, Y. C. Lin, P. T. Liu, Y. M. Kao & J. D. Chen. (2012). Synergistic effect of gamma glutamyltransferase and obesity on metabolic syndrome, independent of hepatic steatosis. Annals of Epidemiology, 22(12), 876-880. DOI : 10.1016/j.annepidem.2012.09.012
DOI
|
10 |
M. Y. Lee et al. (2008). Relationship between gamma-glutamyltransferase and metabolic syndrome in a Korean population. Diabetic Medicine, 25(4), 469-475. DOI : 10.1111/j.1464-5491.2008.02415.x
DOI
|
11 |
O. Niemela. (2016). Biomarker-Based Approaches for Assessing Alcohol Use Disorders. International Journal of Environmental Research and Public Health, 13(2), 166. DOI : 10.3390/ijerph13020166
DOI
|
12 |
K. A. Shin. (2019). Comparison of the serum gamma-glutamyl transferase and serum uric acid levels according to the obesity types based upon on the body mass index in Korean men. Korean Journal of Clinical Laboratory Science, 51(1), 50-56. DOI : 10.15324/kjcls.2019.51.1.50
DOI
|
13 |
M. Penke, W. Kiess & T. Giorgis. (2016). Non-alcoholic fatty liver disease in children and adolescents. Journal of Pediatric Endocrinology and Metabolism, 29(12), 1329-1330. DOI : 10.1515/jpem-2016-0415
DOI
|
14 |
M. Boyraz et al. (2014). Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria. Obesity Research and Clinical Practice, 8(4), e356-e363. DOI : 10.1016/j.orcp.2013.08.003
DOI
|
15 |
V. Regitz-Zagrosek, E. Lehmkuhl & M. O. Weickert. (2006). Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clinical Research in Cardiology, 95(3), 136-147. DOI : 10.1007/s00392-006-0351-5
DOI
|
16 |
M. Tiikkainen et al. (2002). Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obesity Research, 10(9), 859-867. DOI : 10.1038/oby.2002.118
DOI
|
17 |
C. K. Roberts, R. J. Barnard, R. K. Sindhu, M. Jurczak, A. Ehdaie & N. D. Vaziri. (2006). Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism, 55(7), 928-934. DOI : 10.1016/j.metabol.2006.02.022
DOI
|
18 |
E. M. Alissa. (2018). Relationship between serum gamma-glutamyltransferase activity and cardiometabolic risk factors in metabolic syndrome. Journal of Family Medicine and Primary Care, 7(2), 430-434. DOI : 10.4103/jfmpc.jfmpc_194_17
DOI
|
19 |
D. E. Laaksonen, H. M. Lakka, L. K. Niskanen, G. A. Kaplan, J. T. Salonen & T. A. Lakka. (2002). Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. American Journal of Epidemiology, 156(11), 1070-1077. DOI : 10.1093/aje/kwf145
DOI
|
20 |
B. Isomaa et al. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24(4), 683-689. DOI : 10.2337/diacare.24.4.683
DOI
|
21 |
J. Lu et al. (2017). Metabolic Syndrome Among Adults in China: The 2010 China Noncommunicable Disease Surveillance. Journal of Clinical Endocrinology and Metabolism, 102(2), 507-515. DOI : 10.1210/jc.2016-2477
DOI
|
22 |
K. Lee, J. Han & S. G. Kim. (2014). Increasing risk of diabetes mellitus according to liver function alterations in electronic workers. Journal of Diabetes Investigation, 5(6), 671-676. DOI : 10.1111/jdi.12202
DOI
|
23 |
M. Adiels et al. (2006). Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia, 49(4), 755-765. DOI : 10.1007/s00125-005-0125-z
DOI
|
24 |
D. H. Lee, R. Blomhoff & D. R. Jacobs. (2004). Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radical Research, 38(6), 535-539. DOI : 10.1080/10715760410001694026
DOI
|
25 |
P. M. Ridker, P. W. F. Wilson & S. M. Grundy. (2004). Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation, 109(23), 2818-2825. DOI : 10.1161/01.CIR.0000132467.45278.59
DOI
|
26 |
I. Lemieux et al. (2001). Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arteriosclerosis, Thrombosis, and Vascular Biology, 21(6), 961-967. DOI : 10.1161/01.atv.21.6.961
DOI
|
27 |
A. Kerner et al. (2005). Association between elevated liver enzymes and C-reactive protein: possible hepatic contribution to systemic inflammation in the metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology, 25(1), 193-197. DOI : 10.1161/01.ATV.0000148324.63685.6a
DOI
|
28 |
J. M. Park, J. Y. Lee, D. C. Lee & Y. J. Lee. (2017). Serum γ-glutamyltransferase level and metabolic syndrome in children and adolescents: Korean National Health and Nutrition Examination Survey. Journal of Diabetes Investigation, 9(3), 522-528. DOI : 10.1111/jdi.12716
DOI
|
29 |
B. Kasapoglu, C. Turkay, Y. Bayram & C. Koca. (2010). Role of GGT in diagnosis of metabolic syndrome: a clinic-based cross-sectional survey. Indian Journal of Medical Research, 132, 56-61.
|
30 |
S. Lee et al. (2015). Serum gamma-glutamyltransferase levels are associated with concomitant cardiovascular risk factors in Korean hypertensive patients: A nationwide population-based study. Medicine (Baltimore), 94(50), e2171. DOI : 10.1097/MD.0000000000002171
DOI
|
31 |
G. Marchesini & G. Forlani. (2002). NASH: from liver diseases to metabolic disorders and back to clinical hepatology. Hepatology, 35(2), 497-499. DOI : 10.1053/jhep.2002.31551
DOI
|
32 |
B. S. Suh. (2012). The association between serum gamma-glutamyltransferase within normal levels and metabolic syndrome in office workers: A 4-year follow-up study. Korean Journal of Family Medicine, 33(1), 51-58. DOI : 10.4082/kjfm.2012.33.1.51
DOI
|
33 |
D. Z. Banderas, J. Escobedo, E. Gonzalez, M. G. Liceaga, J. C. Ramirez & M. G. Castro. (2012). γ-Glutamyl transferase: a marker of nonalcoholic fatty liver disease in patients with the metabolic syndrome. European Journal of Gastroenterology & Hepatology, 24(7), 805-810. DOI : 10.1097/MEG.0b013e328354044a
DOI
|
34 |
R. A. DeFronzo & E. Ferrannini. (1991). Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 14(3), 173-194. DOI :10.2337/diacare.14.3.173
DOI
|
35 |
G. Erkan, I. Sayin, F. B. Polat, A. Corakci, G. K. Atac & H. Degertekin. (2014). The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study. Turkish Journal of Gastroenterology, 25(Suppl 1), 63-68. DOI : 10.5152/tjg.2014.6233
DOI
|
36 |
K. Lee & J. H. Yang. (2013). Which liver enzymes are better indicators of metabolic syndrome in adolescents: the Fifth Korea National Health and Nutrition Examination Survey, 2010. Metabolic Syndrome and Related Disorders, 11(4), 229-235. DOI : 10.1089/met.2012.0153
DOI
|
37 |
World Health Organization. (2000). The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia.
|
38 |
J. Hung, B. M. McQuillan, P. L. Thompson & J. P. Beilby. (2008). Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. International Journal of Obesity (Lond), 32(5), 772-779. DOI : 10.1038/sj.ijo.0803793
DOI
|
39 |
J. Lugrin, N. Rosenblatt-Velin, R. Parapanov & L. Liaudet. (2014). The role of oxidative stress during inflammatory processes. Biological Chemistry, 395(2), 203-230. DOI : 10.1515/hsz-2013-0241
DOI
|
40 |
M. Hamaguchi et al. (2005). The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Annals of Internal Medicine, 143(10), 722-728. DOI : 10.7326/0003-4819-143-10-200511150-00009
DOI
|
41 |
M. Franzini et al. (2017). Association between plasma gamma-glutamyltransferase fractions and metabolic syndrome among hypertensive patients. Scientific Reports, 7(1), 12003. DOI : 10.1038/s41598-017-12356-w
DOI
|
42 |
M. Lafontan & N. Viguerie. (2006). Role of adipokines in the control of energy metabolism: focus on adiponectin. Current Opinion in Pharmacology, 6(6), 580-585. DOI :10.1016/j.coph.2006.08.002
DOI
|
43 |
L. Tao et al. (2013). Association between γ-glutamyl transferase and metabolic syndrome: a cross-sectional study of an adult population in Beijing. International Journal of Environmental Research and Public Health, 10(11), 5523-5540. DOI : 10.3390/ijerph10115523
DOI
|
44 |
Y. H. Kang, H. K. Min, S. M. Son, I. J. Kim & Y. K. Kim. (2007). The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults. Diabetes Research and Clinical Practice, 77(2), 306-313. DOI : 10.1016/j.diabres.2006.11.009
DOI
|